Skip to content. | Skip to navigation

Personal tools



This folder holds the following references to publications, sorted by year and author.

There are 32 references in this bibliography folder.

Perian, S and Vanacker, JM (2020).
GPER as a Receptor for Endocrine-Disrupting Chemicals (EDCs)
Front Endocrinol, 11(545).

Dard, A, Reboulet, J, Jia, Y, Bleicher, F, Duffraisse, M, Vanaker, JM, Forcet, C, and Merabet, S (2018).
Human HOX Proteins Use Diverse and Context-Dependent Motifs to Interact with TALE Class Cofactors
Cell Rep, 22(11):3058-3071.

Singh, BK, Sinha, RA, Tripathi, M, Mendoza, A, Ohba, K, Sy, JAC, Xie, SY, Zhou, J, Ho, JP, Chang, C, Wu, Y, Giguère, V, Bay, B, Vanacker, J, Ghosh, S, Gauthier, K, Hollenberg, AN, McDonnell, DP, and Yen, PM (2018).
Thyroid hormone receptor and ERRα coordinately regulate mitochondrial fission, mitophagy, biogenesis, and function
Science Signaling, 11(536):eaam5855.

Carnesecchi, J, Cerutti, C, Vanacker, J, and Forcet, C (2017).
ERRalpha protein is stabilized by LSD1 in a demethylation-independent manner.
PLoS One, 12(11):e0188871.

Carnesecchi, J, Forcet, C, Zhang, L, Tribollet, V, Barenton, B, Boudra, R, Cerutti, C, Billas, IM, Serandour, AA, Carroll, JS, Beaudoin, C, and Vanacker, JM (2017).
ERRalpha induces H3K9 demethylation by LSD1 to promote cell invasion
Proc Natl Acad Sci U S A, 114(15):3909-3914.

Bondanese, VP, Lamboux, A, Simon, M, Lafont, JE, Albalat, E, Pichat, S, Vanacker, JM, Telouk, P, Balter, V, Oger, P, and Albarede, F (2016).
Hypoxia induces copper stable isotope fractionation in hepatocellular carcinoma, in a HIF-independent manner
Metallomics, 8(11):1177-1184.

Carnesecchi, J and Vanacker, JM (2016).
Estrogen-Related Receptors and the control of bone cell fate
Mol Cell Endocrinol, 432:37-43.

Griveau, A, Devailly, G, Eberst, L, Navaratnam, N, Le Calve, B, Ferrand, M, Faull, P, Augert, A, Dante, R, Vanacker, JM, Vindrieux, D, and Bernard, D (2016).
The PLA2R1-JAK2 pathway upregulates ERRalpha and its mitochondrial program to exert tumor-suppressive action
Oncogene, 35(38):5033-42.

Tribollet, V, Barenton, B, Kroiss, A, Vincent, S, Zhang, L, Forcet, C, Cerutti, C, Perian, S, Allioli, N, Samarut, J, and Vanacker, JM (2016).
miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRalpha
PLoS One, 11(5):e0156445.

Zhang, L, Wong, J, and Vanacker, JM (2016).
The estrogen-related receptors (ERRs): potential targets against bone loss
Cell Mol Life Sci, 73(20):3781-7.

Carnesecchi, J, Malbouyres, M, de Mets, R, Balland, M, Beauchef, G, Vie, K, Chamot, C, Lionnet, C, Ruggiero, F, and Vanacker, JM (2015).
Estrogens induce rapid cytoskeleton re-organization in human dermal fibroblasts via the non-classical receptor GPR30
PLoS One, 10(3):e0120672.

Vanacker, JM and Maiorano, D (2015).
Checking the cycle by ERRbeta splice variants
Cell Cycle, 14(10):1492-3.

Yuk, JM, Kim, TS, Kim, SY, Lee, HM, Han, J, Dufour, CR, Kim, JK, Jin, HS, Yang, CS, Park, KS, Lee, CH, Kim, JM, Kweon, GR, Choi, HS, Vanacker, JM, Moore, DD, Giguere, V, and Jo, EK (2015).
Orphan Nuclear Receptor ERRalpha Controls Macrophage Metabolic Signaling and A20 Expression to Negatively Regulate TLR-Induced Inflammation
Immunity, 43(1):80-91.

Sailland, J, Tribollet, V, Forcet, C, Billon, C, Barenton, B, Carnesecchi, J, Bachmann, A, Gauthier, KC, Yu, S, Giguere, V, Chan, FL, and Vanacker, JM (2014).
Estrogen-related receptor alpha decreases RHOA stability to induce orientated cell migration
Proc Natl Acad Sci U S A, 111(42):15108-13.

van der Laan, S, Golfetto, E, Vanacker, JM, and Maiorano, D (2014).
Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells
PLoS One, 9(4):e93663.

Zou, C, Yu, S, Xu, Z, Wu, D, Ng, CF, Yao, X, Yew, DT, Vanacker, JM, and Chan, FL (2014).
ERRalpha augments HIF-1 signalling by directly interacting with HIF-1alpha in normoxic and hypoxic prostate cancer cells
J Pathol, 233(1):61-73.

Carnesecchi, J and Vanacker, JM (2013).
The estrogen-related receptors and the adipocyte
Horm Mol Biol Clin Investig, 14(3):107-12.

Gallet, M, Saidi, S, Hay, E, Photsavang, J, Marty, C, Sailland, J, Carnesecchi, J, Tribollet, V, Barenton, B, Forcet, C, Birling, MC, Sorg, T, Chassande, O, Cohen-Solal, M, and Vanacker, JM (2013).
Repression of osteoblast maturation by ERRalpha accounts for bone loss induced by estrogen deficiency
PLoS One, 8(1):e54837.

Bianco, S, Sailland, J, and Vanacker, JM (2012).
ERRs and cancers: effects on metabolism and on proliferation and migration capacities
J Steroid Biochem Mol Biol, 130(3-5):180-5.

Gaude, H, Aznar, N, Delay, A, Bres, A, Buchet-Poyau, K, Caillat, C, Vigouroux, A, Rogon, C, Woods, A, Vanacker, JM, Hohfeld, J, Perret, C, Meyer, P, Billaud, M, and Forcet, C (2012).
Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1
Oncogene, 31(12):1582-91.

Gallet, M and Vanacker, JM (2010).
ERR receptors as potential targets in osteoporosis
Trends Endocrinol Metab, 21(10):637-41.

Gauthier, K, Billon, C, Bissler, M, Beylot, M, Lobaccaro, JM, Vanacker, JM, and Samarut, J (2010).
Thyroid hormone receptor beta (TRbeta) and liver X receptor (LXR) regulate carbohydrate-response element-binding protein (ChREBP) expression in a tissue-selective manner
J Biol Chem, 285(36):28156-63.

Macari, C, Teyssier, C, Tribollet, V, Mouzat, K, Forcet, C, Horard, B, Lobaccaro, JM, and Vanacker, JM (2010).
Estrogens repress PGC1-alpha expression in the uterus
Mol Cell Endocrinol, 330(1-2):33-40.

Vico, L and Vanacker, JM (2010).
Sex hormones and their receptors in bone homeostasis: insights from genetically modified mouse models
Osteoporos Int, 21(3):365-72.

Bianco, S, Lanvin, O, Tribollet, V, Macari, C, North, S, and Vanacker, JM (2009).
Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation
J Biol Chem, 284(35):23286-92.

Document Actions